Flu season visitor restriction – age 16 or older (Restricción de visitantes durante la Temporada de Influenza (Flu) – Mayores de 16 años.)

Flu Season Visitor Restriction

Visitors temporarily restricted to age 16 or older

As a safety first organization, Christiana Care is implementing a temporary visitation age restriction starting Friday, Jan. 18. This temporary restriction protects patients, their loved ones and health care workers during this time of extremely high number of influenza cases and other respiratory illnesses circulating in our community.

The new restrictions limit visitors to patients in Christiana and Wilmington hospitals to persons age 16 or older. Children and teens younger than 16 years are most likely to get the flu and remain contagious longer than adults. This restriction does not apply to outpatient and ambulatory services. We began restricting visitors under the age of 16 years in our Neonatal Intensive Care Unit (NICU) and Women’s and Children’s areas on Jan. 18.

Thank you for your understanding and cooperation.

For more information about the Flu visit our Health Library.


Restricción de visitantes durante la Temporada de Influenza (Flu)

Temporalmente solo se permiten los visitantes mayores de 16 años.

Como una organización que promueve la seguridad ante todo, Christiana Care está implementando una restricción temporal en la edad de visitantes a partir del viernes 18 de enero. Esta restricción temporal protege a los pacientes, a sus seres queridos y al personal de cuidados de salud durante esta época con un número extremadamente alto de casos de influenza y de otras enfermedades respiratorias que circulan en nuestra comunidad.

Las nuevas restricciones, en los hospitales Christiana y Wilmington, sólo permiten visitas a pacientes de personas mayores de 16 años. Los niños y adolescentes menores de 16 años son más propensos a contraer el flu y son contagiosos por más tiempo que los adultos. Esta restricción no aplica a las áreas de servicios ambulatorios. Comenzamos la restricción de visitas a menores de 16 años en nuestra Unidad de Cuidados Intensivos Neonatales (NICU) y en las áreas para Mujeres y Niños desde el 18 de enero.

Gracias por su comprensión y cooperación.

Para más información sobre la gripe, visite nuestra Biblioteca de Salud.

Cancer Research at the
Helen F. Graham Cancer Center
& Research Institute

Tissue Engineering and Regenerative Medicine Program

Program Description

The Tissue Engineering and Regenerative Program at the Helen F. Graham Cancer Center & Research Institute brings together a multi-disciplinary team of biologists, bioengineers, clinicians and materials science engineers to work towards engineering of glandular tissues/organs. This program has mainly focused on regeneration of the salivary glands but aims to expand toward engineering of other glandular tissues. The Salivary Group constitutes a multi-institutional team that includes the researchers at the Helen F. Graham Cancer Center & Research Institute, the University of Delaware (UD), Rice University / Bioscience Research Collaborative (BRC), National Institute of Dental and Craniofacial Research (NIDCR), University of Michigan, and the Alleghany Health Network (AHN). Our salivary gland work is funded by a multi-institutional R01 from the National Institutes of Health.

Objectives

  • Using biomedical engineering principles to study and recreate organ systems from the molecular and cellular level.
  • Studying the behavior of isolated primary/progenitor cells in 3D biomimetic material scaffolds by dialing in unique biological cues.
  • Evaluate surgical protocols to determine the best techniques to implant a neo-tissue/organ that can be functional in an animal model.

Current Research Areas

  • Functional restoration of salivary glands to relieve xerostomia.
  • Regeneration of the lacrimal glands and the conjunctiva.
  • Reconstitution of eccrine, apocrine and sebaceous glands for incorporation in reconstructed skin.
  • Generating 3D models of normal mammary spheroids from isolated primary/progenitor cells for use in in vitro studies.

Members

Swati Pradhan-Bhatt, Ph.D., Helen F. Graham Cancer Center & Research Institute/University of Delaware.
Robert L. Witt, M.D., Helen F. Graham Cancer Center & Research Institute/University of Delaware.
Mary C. Farach-Carson, Ph.D., Rice University/Bioscience Research Collaborative.
Xinqiao Jia, Ph.D., University of Delaware.
Padma P. Srinivasan, Ph.D., Helen F. Graham Cancer Center & Research Institute/University of Delaware.
Daniel A. Harrington, Ph.D., Rice University/Bioscience Research Collaborative.
Matthew P. Hoffman, Ph.D., National Institute of Dental and Craniofacial Research.
Michael Passineau, Ph.D., Allegheny Health System.
Isabelle Lombaert, Ph.D., University of Michigan.
Vaishali Patel, Ph.D., National Institute of Dental and Craniofacial Research.
Tugba Odzemir, Ph.D., University of Delaware
Danielle Wu, Ph.D., Rice University/Bioscience Research Collaborative.

Cancer Research Program
Helen F. Graham Cancer Center & Research Institute
4701 Ogletown-Stanton Road, Newark, DE 19713 directions
For more information, call 302-623-4450 or e-mail us.